Williams ED (1966) Histogenesis of medullary carcinoma of the thyroid. Journal of Clinical Pathology 19:114–118

CAS  Article  Google Scholar 

Tashjian AH, Melvin KEW (1968) Medullary Carcinoma of the Thyroid Gland. New England Journal of Medicine 279:279–283

Article  Google Scholar 

Kebebew E, Ituarte PHG, Siperstein AE, Duh Q-Y, Clark OH (2000) Medullary thyroid carcinoma. Cancer 88:1139–1148

CAS  Article  Google Scholar 

Opsahl EM, Akslen LA, Schlichting E, et al (2019) Trends in Diagnostics, Surgical Treatment, and Prognostic Factors for Outcomes in Medullary Thyroid Carcinoma in Norway: A Nationwide Population-Based Study. European Thyroid Journal 8:31–40

CAS  Article  Google Scholar 

Turkdogan S, Forest V-I, Hier MP, Tamilia M, Florea A, Payne RJ (2018) Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer. J of Otolaryngol - Head & Neck Surg 47:55

Article  Google Scholar 

Elisei R, Cosci B, Romei C, et al (2008) Prognostic Significance of Somatic RET Oncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study. The Journal of Clinical Endocrinology & Metabolism 93:682–687

CAS  Article  Google Scholar 

Lindsey SC, Ganly I, Palmer F, Tuttle RM (2015) Response to Initial Therapy Predicts Clinical Outcomes in Medullary Thyroid Cancer. Thyroid 25:242–249

Article  Google Scholar 

Travis W, Brambilla E, Burke A (2015) WHO classification of tumours of the lung, pleura, thymus and heart., 4th ed. International Agency for Research on Cancer., Lyon

Lloyd R, Osamura R, Kloppel G (2017) WHO classification of tumours of endocrine organs. International Agency for Research on Cancer (IARC), Lyon

Alzumaili B, Xu B, Spanheimer PM, Tuttle RM, Sherman E, Katabi N, Dogan S, Ganly I, Untch BR, Ghossein RA (2020) Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome. Mod Pathol 33:1690–1701

CAS  Article  Google Scholar 

Fuchs TL, Nassour AJ, Glover A, et al (2020) A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis. American Journal of Surgical Pathology 44:1419–1428

Article  Google Scholar 

Xu B, Fuchs TL, Ahmadi S, et al (2022) International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma. JCO 40:96–104

Article  Google Scholar 

Najdawi F, Ahmadi S, Capelletti M, Dong F, Chau NG, Barletta JA (2021) Evaluation of grade in a genotyped cohort of sporadic medullary thyroid carcinomas. Histopathology 79:427–436

Article  Google Scholar 

Hazard J, Hawk W, Crile G (1959) Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity. J Clin Endocrinol Metab 19:152–61

CAS  Article  Google Scholar 

Williams ED, Brown CL, Doniach I (1966) Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid. Journal of Clinical Pathology 19:103–113

CAS  Article  Google Scholar 

Ríos A, Rodríguez JM, Acosta JM, Balsalobre MD, Torregrosa N, Sola J, Pérez-Flores D, Parrilla P (2010) Prognostic Value of Histological and Immunohistochemical Characteristics for Predicting the Recurrence of Medullary Thyroid Carcinoma. Ann Surg Oncol 17:2444–2451

Article  Google Scholar 

Dottorini ME, Assi A, Sironi M, Sangalli G, Spreafico G, Colombo L (1996) Multivariate analysis of patients with medullary thyroid carcinoma: Prognostic significance and impact on treatment of clinical and pathologic variables. Cancer 77:1556–1565

CAS  Article  Google Scholar 

Franc B, Rosenberg-Bourgin M, Caillou B, et al (1998) Medullary thyroid carcinoma: Search for histological predictors of survival (109 proband cases analysis). Human Pathology 29:1078–1084

CAS  Article  Google Scholar 

Tisell LE, Oden A, Muth A, Altiparmak G, Mõlne J, Ahlman H, Nilsson O (2003) The Ki67 index a prognostic marker in medullary thyroid carcinoma. Br J Cancer 89:2093–2097

CAS  Article  Google Scholar 

Mian C, Pennelli G, Barollo S, et al (2011) Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification. European Journal of Endocrinology 164:971–976

CAS  Article  Google Scholar 

Baloch ZW, Asa SL, Barletta JA, et al (2022) Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol 33:27–63

Article  Google Scholar 

Voss SM, Riley MP, Lokhandwala PM, Wang M, Yang Z (2015) Mitotic Count by Phosphohistone H3 Immunohistochemical Staining Predicts Survival and Improves Interobserver Reproducibility in Well-differentiated Neuroendocrine Tumors of the Pancreas. American Journal of Surgical Pathology 39:13–24

Article  Google Scholar 

Ozturk Sari S, Taskin OC, Gundogdu G, Yegen G, Onder S, Keskin M, Saglam S, Ozluk Y, Gulluoglu M, Mete O (2016) The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors. Endocr Pathol 27:162–170

CAS  Article  Google Scholar 

Warth A, Fink L, Fisseler-Eckhoff A, et al (2013) Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids. Virchows Arch 462:507–513

CAS  Article  Google Scholar 

Swarts DRA, van Suylen R-J, den Bakker MA, et al (2014) Interobserver Variability for the WHO Classification of Pulmonary Carcinoids. American Journal of Surgical Pathology 38:1429–1436

Article  Google Scholar 

McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 22:276–282

Article  Google Scholar 

Mete O, Erickson LA, Juhlin CC, de Krijger RR, Sasano H, Volante M, Papotti MG (2022) Overview of the 2022 WHO Classification of Adrenal Cortical Tumors. Endocr Pathol 33:155–196

Article  Google Scholar 

Hellgren LS, Stenman A, Paulsson JO, Höög A, Larsson C, Zedenius J, Juhlin CC (2022) Prognostic Utility of the Ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center. Endocr Pathol. https://doi.org/10.1007/s12022-022-09714-4

Article  PubMed  Google Scholar 

Erickson LA, Mete O, Juhlin CC, Perren A, Gill AJ (2022) Overview of the 2022 WHO Classification of Parathyroid Tumors. Endocr Pathol 33:64–89

Article  Google Scholar 

Reid MD, Bagci P, Ohike N, et al (2015) Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies. Mod Pathol 28:686–694

Article  Google Scholar 

Tang LH, Gonen M, Hedvat C, Modlin IM, Klimstra DS (2012) Objective Quantification of the Ki67 Proliferative Index in Neuroendocrine Tumors of the Gastroenteropancreatic System: A Comparison of Digital Image Analysis With Manual Methods. American Journal of Surgical Pathology 36:1761–1770

Article  Google Scholar 

Matsukuma K, Olson KA, Gui D, Gandour-Edwards R, Li Y, Beckett L (2017) Synaptophysin-Ki67 double stain: a novel technique that improves interobserver agreement in the grading of well-differentiated gastrointestinal neuroendocrine tumors. Mod Pathol 30:620–629

CAS  Article  Google Scholar 

Blank A, Wehweck L, Marinoni I, Boos LA, Bergmann F, Schmitt AM, Perren A (2015) Interlaboratory variability of MIB1 staining in well-differentiated pancreatic neuroendocrine tumors. Virchows Arch 467:543–550

CAS  Article  Google Scholar